2024 News and Events
February 29 - March 2
Dr. Atkinson presents his work at ACTRIS Forum 2024 West Palm Beach.
May 5 - 9
Dr. Jerome presents his work at ARVO 2024 Annual meeting Seattle, WA.
July 2024
Annual summer gathering to celebrate lab achievements, including new publications, grants of 2024, and promotions.
Past News and Events
January
Congratulations for Dr. Ashley Munie graduated! She will continue her postdoc training at Jackson laboratory.
February 23-25
Dr. Atkinson present his work ACTRIS Forum 2023 in San Diego, CA.
April 23-27
Dr. Jerome and Dr. Sas presented their work in ARVO annual meeting New Orleans.
August 31
Lab annual party.
December
Department holiday party.
Segal's Seagulls were crowned the 2022 champions of the Faculty and Staff Dodgeball Classic. The team won all five of their matchups to bring the championship back to the department!
October 2020
Research led by Segal Lab investigators at The Ohio State University Wexner Medical Center provides new hope for recovery from degenerative neurological diseases — such as ALS and multiple sclerosis — as well from as damage caused by traumatic brain and spine injuries and stroke. LEARN MORE
May 2020
A former lab member, Dr. David Giles, has just graduated from the MD/PhD program at the University of Michigan. We wish him the best of luck in his new position as a Neurosurgery Resident at Washington University in Saint Louis!
February 27-29, 2020
Dr. Taryn Mockus and Dr. Jeff Atkinson attended the Fifth Annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2020. The Forum was held in West Palm Beach, Florida.
January 9-11, 2020
Several Segal Lab members traveled to Austin, TX to attend the ACTRIMS Young Scientist Summit.
September 13, 2019
ECTRIMS Travel Award Given to Segal Lab Member - Postdoc Jeffrey Atkinson received a travel award from the European Committee for Research and Treatment of Multiple Sclerosis to support his travel to present at the ECTRIMS Congress in Stockholm, Sweden, in September 2019.
February 27 - March 2, 2019
ACTRIMS Forum, Dallas, TX
February 12, 2019
ACTRIMS Young Scientist Summit
Dr. Segal, along with lab members Dr. Jeff Atkinson and PhD student Ashley Munie, traveled to Savannah in January to attend the ACTRIMS Young Scientist Summit. Dr. Segal, a member of ACTRIMS Board of Directors, provided both the Introductory and Closing remarks.
November 15, 2018 – Patrick Duncker, PhD Defense
http://immunology.medicine.umich.edu/people/patrick-duncker
October 31, 2018 – Ashley Munie, Immunology Research Seminar
http://immunology.medicine.umich.edu/immunology-journal-club
October 19, 2018 – Dr. Andrew Sas, Neurology Research Seminar
August 22, 2018 – Dr. Benjamin Segal, 3rd Annual Payer & Provider Workshops in Multiple Sclerosis
August 17, 2018 – Jesse Washnock-Schmid’s Going Away Party
August 2, 2018 – ECTRIMS Travel Award Given to Segal Lab Member
PhD Student Patrick Duncker received a travel award from the European Committee for Research and Treatment of Multiple Sclerosis (ECTRIMS) to support his travel to present at the ECTRIMS Congress in Berlin, Germany in October of this year.
July 17, 2018 - New Paper Highlights Pathway to CNS Lesion Localization
The Segal Lab has published a new (July 16, 2018) paper in the Journal of Neuroinflammation detailing evidence of a previously undiscovered mechanism in which cytokines IFNγ and CXCL2 interact to regulate central nervous system lesion location in an experimental allergic encephalomyelitis (EAE) mouse model. You can read the full abstract via PubMed at this link.
July 7-13, 2018 FASEB Translational Neuroimmunology
Dr. Andrew Sas, Patrick Duncker and Dr. Jeff Atkinson presenting at FASEB.
June 1, 2018 Andrew Sas gives talk at the 15th Annual Neurobiology of Disease Symposium at the University of Michigan
June 7, 2018 – 17th Annual Immunology Retreat
April 16, 2018 Dr. Segal explains the huge advances in MS Treatment
It was surprising for many of us when a well-known actress recently revealed she’s been dealing with multiple sclerosis (MS) for 15 years. Jamie Lynn Sigler said in interviews she was symptom-free for a long time, and now takes medication to keep her symptoms stable.Dr. Benjamin Segal, Holtom-Garrett Professor of Neurology and director of the U-M Multiple Sclerosis Center, explains that MS treatment has grown by leaps and bounds in the past 20 years.“I myself have many patients who are high-functioning, successful contributors to society, from CEOs and professors to doctors and lawyers. Many of these individuals have no signs of MS that are apparent to co-workers or acquaintance,” Segal wrote.
Read the full blog: http://uofmhealthblogs.org/neurohealth/a-revolution-in-ms-treatment/27090/
May 30, 2018 – Neurobiology of Disease Symposium
February 4, 2018 - Patrick Duncker awarded second place for best oral presentation at ACTRIMS 2018 (from over 220 abstracts submitted)
February 1, 2018- Patrick Duncker, Andrew Sas, and Nikki Wilkinson present posters at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) meeting
December 15, 2017 – David Giles, MD/PhD student, successfully defends his thesis
April 16, 2016 - Progressive MS at ACTRIMS 2016
The 2016 ACTRIMS Forum met in New Orleans on Feb 18-20, and at its conclusion was a panel discussion on new insights in MS clinical management and progression. Watch the full hour debate, https://primeinc.org/22WB163
Panel speakers, in order of appearance:
- Suhayl Dhib-Jalbut, MD
- Fiona Costello, MD, FRCP
- Benjamin M Segal, MD
- Andrew D Goodman, MD
Leveraging ground-breaking findings in progressive MS presented at recent national and international meetings, 4 leading MS experts explore and debate new insights in the understanding and practical clinical implications for the neurology team managing patients with MS, including early identification of patients with and transitioning to progressive disease. This interactive online/mobile video panel discussion, recorded at the conclusion of the Annual ACTRIMS Forum 2016, “Progressive MS: From Bench to Bedside and Back,” also reveals advances in MS radiology and new clinical trial evidence on novel and emerging therapies for progressive MS. Throughout the video experience, learners will have the unique opportunity to submit questions to the expert faculty and register to participate in live teleconference Q&A sessions.
Watch the full hour discussion, Free access: https://primeinc.org/29WB158
Lab Fun
